By analysis of in silico predictions and family segregation, c.126C > G was classified as likely pathogenic; therefore, it expanded the mutational spectrum of NIPA1. The patient carrying this novel variant presented with a pure HSP. This evidence concerns the gene NIPA1 and hereditary spastic paraplegia.